Zhang Ning

Title: Zhang Ning - Innovator in Angiogenesis Research

Introduction

Zhang Ning is a prominent inventor based in Alameda, CA (US). He has made significant contributions to the field of biomedical research, particularly in the area of angiogenesis. His innovative work has led to the development of methods and compositions that are crucial for screening angiogenesis-modulating compounds.

Latest Patents

Zhang Ning holds a patent titled "Methods and compositions for screening for angiogenesis modulating compounds." This invention relates to novel transcription control elements, including promoters derived from angiogenesis-related genes, particularly the mouse VEGF gene, the mouse VEGFR-2 receptor gene, and the mouse Tie2 gene. The patent also discloses isolated polynucleotides comprising such promoters, as well as nucleic acid constructs that are operatively linked to genes encoding various gene products. Furthermore, it details screening methods using recombinant cells and transgenic animals to identify therapeutic compounds that modulate tumorigenesis and angiogenesis.

Career Highlights

Zhang Ning has had a successful career, working at Xenogen Corporation, where he has been able to apply his expertise in innovative research. His work has not only advanced scientific understanding but has also paved the way for potential therapeutic applications in cancer treatment.

Collaborations

Throughout his career, Zhang has collaborated with notable colleagues, including Pamela R Contag and Anthony Purchio. These collaborations have further enriched his research and contributed to the advancement of the field.

Conclusion

Zhang Ning is a distinguished inventor whose work in angiogenesis research has significant implications for therapeutic development. His innovative approaches and collaborations continue to influence the biomedical field positively.